For the last 60 years, Woodcock Washburn LLP has worked hard to establish itself as one of the foremost intellectual property boutiques, and the firm has no plans to budge from its hard-earned spot at the top.
Two seasoned lawyers at Schiffrin & Barroway LLP have moved up the ranks to named partners, as the shareholder litigation and class action firm opens its first office in California.
The U.S. Court of Appeals for the Federal Circuit on Wednesday rejected a request to review an earlier ruling that reinstated a long-running patent dispute between Tyco Healthcare Group LP and Medrad Inc.
Medical device maker Synthes (U.S.A) is suing Stryker Corporation for allegedly breaking its seven-year-old bone plate patent.
Headaches continue to mount for brokerage firms with yet another lawsuit alleging a company, this time Legg Mason, dodged labor laws by not compensating its brokers for overtime work.
Employers will be confronted with new challenges in 2007, as the 110th Congress is expected to consider legislation that could expand workers’ rights, raise the federal minimum wage and empower labor unions.
UnitedHealthcare agreed Tuesday to reimburse hundreds of New Yorkers who were unfairly charged for out-of-network services due to errors on its physician directory.
The U.S. Securities and Exchange Commission has suspended a former portfolio manager after determining he took part in unauthorized trades that led to the loss of more than $415 million for pension funds and investors.
Scrambling to halt shipments of a generic copy of the antidepressant Wellbutrin XL, Canadian pharmaceutical company Biovail Corp. has renewed its fight against the U.S. Food and Drug Administration in another lawsuit.
United Parcel Service Inc. has agreed to shell out $100,000 to settle a discrimination lawsuit brought by the Equal Employment Opportunity Commission on behalf of a former employee.
Chase Bank USA and Trilegiant Corp. agreed Monday to pay 17 states a combined $14.5 million to settle allegations that they used deceptive means to lure thousands of consumers into signing up for unwanted membership programs.
Cigna Corp. has agreed to shell out $93 million to settle a securities class action filed in Pennsylvania in 2002, accusing the insurers and its executives of lying to investors about its plan to overhaul its outdated computer systems.
Tyco Healthcare Group LP suffered a setback Wednesday when a federal judge denied its motion for an injunction in a trademark infringement case over maxi pad marketing terminology.
After a seven-day bench trial, attorneys for Pfizer Inc. and generic drug maker Mylan Pharmaceuticals Inc. made closing arguments Wednesday, putting the final touch on a longstanding patent infringement suit over Pfizer’s blockbuster drug Norvasc.
The number of company bankruptcy filings dropped 20% in fiscal year 2006, the fifth straight year a decline was reported, according to statistics released Tuesday by the Administrative Office of the U.S. Courts.
Plaintiffs firms hoping to cash in on the litigation over excessive brokers’ fees suffered a setback this week when a New Jersey district judge dismissed a class action lawsuit against private money manager Lord Abbett & Co. LLC.
In just one of the many wage and hour suits filed against Wal-Mart Stores Inc. nationwide, a state judge has granted class action status to every Wal-Mart hourly employee in Kentucky who failed to receive proper rest and meal breaks.
A multimillion-dollar settlement involving Zurich American Insurance Co. has been finalized, allowing the company to pay $121.8 million to settle bid-rigging and price-fixing allegations in 11 states.
Just days after the European Union levied a €519 million fine against five companies for allegedly fixing prices for synthetic rubbers, a proposed class action was filed in U.S. federal court on Thursday on behalf of companies and individuals that purchased rubber from the alleged cartel.
Just a month after GlaxoSmithKline PLC agreed to pay $63.8 million to settle claims in a class action lawsuit over its antidepressant drug Paxil, the U.K. drug maker is facing another slew of lawsuits over birth defects allegedly caused by the drug.